Latest Commercial Expansion News

Page 9 of 13
Control Bionics Limited has announced a $2.06 million non-renounceable rights issue to fund the commercial expansion of its NeuroStrip device and bolster NeuroNode operations. The capital raise is underwritten to approximately $1.15 million by major shareholders and strategic partners.
Victor Sage
Victor Sage
28 Aug 2025
Micro-X reported FY25 revenue of $13.1 million, underpinned by significant US government contracts and pioneering 3D head CT imaging technology, setting the stage for clinical trials and commercial expansion.
Victor Sage
Victor Sage
28 Aug 2025
Decidr AI Industries has locked in a $3.9 million underwriting agreement with Morgans Corporate Limited to back the exercise of listed options expiring this month, providing crucial funding ahead of its DecidrOS Beta release.
Sophie Babbage
Sophie Babbage
26 Aug 2025
Imricor Medical Systems reports significant regulatory approvals and clinical trial progress, positioning itself as a disruptive force in the growing electrophysiology market. With a strengthened commercial pipeline and solid cash reserves, the company is poised for a pivotal growth phase.
Ada Torres
Ada Torres
26 Aug 2025
INOVIQ Limited reported a $6.9 million net loss for FY25 while making significant strides in its exosome-based cancer diagnostics and therapeutics pipeline, including a breakthrough ovarian cancer screening test and promising CAR-exosome therapy results.
Ada Torres
Ada Torres
22 Aug 2025
Artrya Limited reported a 17.2% increase in net loss to $16.4 million for FY25, while achieving FDA clearance and launching its AI-driven Salix platform in the U.S. market. The company also secured key commercial partnerships in Australia and raised $20 million in equity funding.
Ada Torres
Ada Torres
20 Aug 2025
EcoGraf Limited reveals a major breakthrough in its HFfree® graphite purification technology, cutting operating costs by 25% and projecting a US$282 million NPV for its initial 25,000 tonnes per annum facility. This positions the company as a competitive, eco-friendly supplier amid rising global demand and geopolitical shifts in battery materials.
Maxwell Dee
Maxwell Dee
13 Aug 2025
Firebird Metals has received a significant Expression of Interest from Taza Metal Technologies to purchase up to five of its energy-efficient kilns, potentially generating over US$10 million in revenue. This marks a key step in Firebird’s international commercial expansion and highlights its leadership in sustainable manganese processing technology.
Maxwell Dee
Maxwell Dee
5 Aug 2025
Telix Pharmaceuticals has recast its historical financials from AUD to USD to better reflect its US-centric revenue streams and reports increased operating expenditure tied to recent acquisitions and growth initiatives.
Ada Torres
Ada Torres
5 Aug 2025
Advanced Health Intelligence Ltd has secured up to AUD 5.5 million from Oakley Capital Partners to support its ASX reinstatement and global growth ambitions, while targeting an additional USD 6 million from strategic investors and unlocking AUD 3 million in R&D grants.
Ada Torres
Ada Torres
31 July 2025
4DMedical has landed a $10 million strategic investment from Pro Medicus, aimed at accelerating its commercial growth and advancing its CT – VQ™ technology towards FDA clearance in the US.
Ada Torres
Ada Torres
31 July 2025
4DMedical reports a 56% revenue surge in FY25 alongside a strategic $10 million investment from Pro Medicus, advancing its CT, VQ™ lung imaging technology towards FDA clearance.
Ada Torres
Ada Torres
31 July 2025